2,6-Diaminopurine

2,6-Diaminopurine

SCHEMBL6755680

Nc1nc(N)c2[nH]cnc2n1.Nc1nc2nn[nH]c2c(=O)[nH]1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 2/20 0.61
▸ PDPK1 O15530 1/20 0.57
▸ GDA Q9Y2T3 1/20 0.57
▸ DPP4 P27487 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ CDK2 P24941 7/20 0.41
▸ MAP3K5 Q99683 1/20 0.39
▸ CDK1 P06493 6/20 0.36
▸ CCNB1 P14635 6/20 0.36
▸ CCNA2 P20248 6/20 0.36
▸ CCNA1 P78396 6/20 0.36
▸ MGMT P16455 3/20 0.36
▸ GRIA1 P42261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanine SCHEMBL29217335 0.90 PNP (0.77) PNPGDADPP4KDM4EMEN1
2,6-Diaminopurine SCHEMBL1825533 0.88 PNP (0.79) PNPPDPK1GDADPP4KDM4E
Thioguanine SCHEMBL27562480 0.84 PNP (0.62) PNPPDPK1GDADPP4KDM4E
8-Azaguanine SCHEMBL26817 0.79 PNP (0.61) PNPKDM4EMEN1ALDH1A1MAPT
Guanine SCHEMBL28330713 0.78 PNP (0.93) PNPPDPK1GDADPP4KDM4E
Guanine SCHEMBL986801 0.78 PNP (1.00) PNPPDPK1GDADPP4KDM4E
Guanine SCHEMBL5260 0.78 PNP (1.00) PNPPDPK1GDADPP4KDM4E
Guanine SCHEMBL1264884 0.78 PNP (1.00) PNPPDPK1GDADPP4KDM4E
Guanine SCHEMBL9511597 0.76 PNP (0.96) PNPPDPK1GDADPP4KDM4E
Guanine SCHEMBL22533907 0.76 PNP (0.96) PNPPDPK1GDADPP4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004053168-A1 MODULATION OF ADIPOPHILIN EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2004-06-24 — — WO disclosed
Send feedback